Developed by Oxford University's renowned pathogen genomics team and supported by Oracle Inc.'s cloud computing capabilities, GPAS is a turn-key solution that automates and accelerates the processing, analysis, and comparison of genomic sequencing data. Initially focused on SARS-CoV-2, GPAS will quickly expand to analyze other pathogens like M. tuberculosis. The system delivers these solutions to laboratories, hospitals, and public health organizations worldwide, enabling global genomic sequencing analysis for improved disease control and prevention.